Control Group (n = 35) | ORC Group (n = 35) | P value | |
---|---|---|---|
Gender(male/female, n) | 13/22 | 13/22 | 1 |
Age(year) | 65.43 ± 5.86 | 64.86 ± 6.11 | 0.691 |
BMI(kg/m2) | 25.23 ± 2.60 | 25.70 ± 2.50 | 0.445 |
ASA grade(II/III, n) | 30/5 | 29/6 | 0.743 |
Preoperative-Hb(g/L) | 133.26 ± 14.38 | 135.63 ± 15.19 | 0.505 |
Preoperative-Hct(%) | 40.44 ± 3.88 | 41.16 ± 4.55 | 0.479 |
Platelet count(×109/L) | 207.03 ± 62.53 | 212.46 ± 55.80 | 0.703 |
PBV(ml) | 4135.63 ± 547.33 | 4128.47 ± 553.29 | 0.957 |
Preoperative coagulation index | |||
PT(s) | 11.37 ± 1.21 | 11.53 ± 0.92 | 0.791 |
PTA(%) | 108.02 ± 11.67 | 107.97 ± 9.84 | 0.805 |
INR | 0.94 ± 0.096 | 0.94 ± 0.073 | 0.814 |
APTT(s) | 29.98 ± 2.71 | 29.88 ± 3.09 | 0.889 |
TT(s) | 16.64 ± 0.85 | 16.71 ± 1.05 | 0.745 |
FIB(g/L) | 3.05 ± 0.54 | 3.19 ± 0.69 | 0.340 |